{
    "informations": {
        "total_answer": 44,
        "correct_answer": 10
    },
    "data": [
        {
            "filename": "2022_EPAC_mcq.json",
            "questions": [
                {
                    "question": "A communication pursuant to Article 94(3) EPC is dated 7 December 2022. In the communication a time limit of four months is set for replying to objections raised by the examining division.  Which of the following statements is not  correct?",
                    "options": [
                        "A.  The communication is deemed to be delivered on 17 December 2022",
                        "B. The time limit for replying to the communication expires on 17 April 2023",
                        "C.  Further processing for replying to the communication can be validly requested on 19 June 2023 at the latest",
                        "D.  An extension of the time limit for filing the reply can be validly requested on 14 April 2023"
                    ]
                },
                {
                    "question": "You filed a European patent application which discloses a new amino acid sequence. This sequence is however only used in a single example and is not part of the claims. No sequence listing was filed.  Which of the following statements is correct?",
                    "options": [
                        "A. If you are invited by the EPO to file a sequence listing, you need to file it and pay a late furnishing fee to the EPO",
                        "B. If you are invited by the EPO to file a sequence listing and do not react to this invitation in due time, the application is deemed to be withdrawn",
                        "C. If you are invited by the EPO to file a sequence listing, you need to file it in PDF format",
                        "D. You do not need to file any sequence listing because the amino acid sequence is not claimed"
                    ]
                },
                {
                    "question": "During the examination proceedings the applicant notes that claim 1 contains a typographical error. What is the last point in time for requesting correction of the error under Rule 139 EPC?",
                    "options": [
                        "A. One day before the decision to grant a European patent is handed over to the EPO postal service",
                        "B. Date  of publication of the mention of the grant of the European patent",
                        "C. Date of notification of the decision to grant",
                        "D. Date of the communication under Rule 71(3) EPC"
                    ]
                },
                {
                    "question": "Antonia, an applicant living in Argentina and having Argentinian nationality, intends to file a European patent application EP -A and an international patent application PCT- A.  Which of the following statements is correct?",
                    "options": [
                        "A. Antonia can validly file PCT- A with the International Bureau of WIPO",
                        "B. Antonia can validly file PCT -A with the EPO",
                        "C. Antonia can validly file EP -A with the EPO",
                        "D. None of the above"
                    ]
                },
                {
                    "question": "Applicant X filed European patent application EP -X on 23 August 2019 as a first filing. The applicant filed application EP -Y as a divisional application of EP- X on 26 September 2022. Please consider the following statements:   2 I. The renewal fee for the fourth year for EP -X was due on 31 August 2022; the renewal fees for the third and fourth years for EP -Y were due on 26 September 2022 II. The renewal fee for the fourth year for EP -X can be validly paid on 28 February 2023 together with the necessary additional fee; the renewal fees for the third and fourth years for EP -Y can be validly paid without additional fee up to 31 January 2023  Which of the following items applies?",
                    "options": [
                        "A. Only statement I is correct",
                        "B. Only statement II is correct",
                        "C. Both statements I and II are correct",
                        "D. Both statements I and II are incorrect"
                    ]
                },
                {
                    "question": "The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?",
                    "options": [
                        "A. 2 February 2023",
                        "B. 13 February 2023",
                        "C. 5 February 2023",
                        "D. 6 February 2023"
                    ]
                },
                {
                    "question": "An international patent application was filed on 17 February 2022 claiming priority from a European patent application filed on 17 February 2021. The international search report together with the written opinion was transmitted to the applicant on 10 June 2022.   What is the last day for filing a demand for international preliminary examination?",
                    "options": [
                        "A. 17 December 2022",
                        "B. 19 December 2022",
                        "C. 10 September 2022",
                        "D. 12 September 2022"
                    ]
                },
                {
                    "question": "A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?",
                    "options": [
                        "A.  For both I and II a power of attorney signed by each applicant is always required",
                        "B.  For I a power of attorney signed by each applicant is always required",
                        "C.  For II a power of attorney signed by each applicant is always required",
                        "D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3"
                    ]
                },
                {
                    "question": "Which of the following steps is not a minimum requirement for entry into the European phase?",
                    "options": [
                        "A.  Supplying a translation if the Euro- PCT application was not published in one of the EPO's official languages",
                        "B.  Specifying the application documents on which the European grant procedure is to be based",
                        "C.  Filing the designation of the inventor",
                        "D.  Paying the search fee if a supplementary European search report is to be drawn up"
                    ]
                },
                {
                    "question": "A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?",
                    "options": [
                        "A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings",
                        "B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English",
                        "C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings",
                        "D.  None of  the above"
                    ]
                },
                {
                    "question": "Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?",
                    "options": [
                        "A. Lithuania",
                        "B. France",
                        "C. Italy",
                        "D. None of the above"
                    ]
                },
                {
                    "question": "International patent application PCT- 1 was filed on 6 May 2021 without claiming priority. The application consists of 21 pages, including 17 claims. The international search was carried out by the EPO acting as ISA, and the international application was published together with the international search report after 18 months. On 12 December 2022, early entry into the European phase is requested. Which minimum requirement(s) must be fulfilled to validly effect early entry into the European phase according to Article 23(2) PCT?",
                    "options": [
                        "A. Payment of the filing fee",
                        "B. Payment of the filing fee and claims fees",
                        "C. Payment of the filing fee, the claims fees, the examination fee, the designation fee and the renewal fee for the third year",
                        "D. Payment of the filing fee, the designation fee and the examination fee"
                    ]
                },
                {
                    "question": "What is the last point in time for an effective withdrawal of a European patent application?",
                    "options": [
                        "4 A.  Date of receipt of the communication under Rule 71(3) EPC",
                        "B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO",
                        "C.  Date of publication of the mention of the grant in the European Patent Bulletin",
                        "D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin"
                    ]
                },
                {
                    "question": "A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?",
                    "options": [
                        "A. This error in the published specification of this European patent may never be corrected",
                        "B. This error in the published specification of this European patent may be corrected at any time",
                        "C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending",
                        "D. The error may only be corrected if opposition proceedings are pending"
                    ]
                },
                {
                    "question": "On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?",
                    "options": [
                        "A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months",
                        "B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated",
                        "C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time",
                        "D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A"
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "C",
                    "Justification": "The question was which of the following statements  is not correct. Statements A, B, D  are correct. Statement C is not correct  because further  processing can be requested later than 19 June 2023, namely within  two months of a loss -of-right communication. Legal basis Rule 126(2) EPC Where notification is effected by registered letter , the letter shall be deemed to be delivered to the addressee on the tenth day  following its handover to the postal service provider unless it has failed to reach the addressee or has reached him at a later date . Rule 135(1) EPC Further processing under  Article 121, paragraph  1, shall be requested by payment of the prescribed fee within two months of the communication concerni ng either the failure to observe a time limit or a loss of rights . The omitted act shall be completed within the period for making the request. Rule 132(2) EPC In special cases, the period may be extended upon request, presented before the expiry of such  period . "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Rule 30(3) EPC Where the applicant has not filed a sequence listing complying with the requirements under  paragraph  1 at the date of filing, the European Patent Office shall invite the applicant to furnish such a sequence listing and pay the late furnishing fee . If the applicant does not furnish the required sequence listing and pay the required late furnishing fee within a period of two months after such an invitation, the application shall be refused . Decision of the President of the EPO dated 9 December 2021 on the filing of sequence listings , Article  1(1) If nucleotide or amino acid sequences are disclosed in a European patent application, the description must contain a sequence listing in XML  format complying with WIPO Standard  ST.26. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Board of Appeal  decision  G12/91 Guidelines for Examination in the EPO , H-VI, 2.1 : The decision -making process  is terminated on the date of handing over of the decision to grant to the EPO 's postal service . 2 "
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis States party to the PCT and the Paris Convention and m embers of the World Trade Organization (wipo.int) : Argentina is not a PCT contracting state Article 58 EPC A European patent application may be filed by any natural or legal person, or anybody equivalent to a legal person by virtue of the law governing  it. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Rule 51(1) EPC A renewal fee for the coming year  is due on the last day of the month containing the anniversary of the date of filing, i.e. on 31 August 2022 . Rule 51(2) EPC If a renewal fee is not paid on the due date under  paragraph 1 , the fee may still be paid within six months of the said date, i.e . on 28 February 2023, provided that an additional fee is also paid within that period . Rule 51(3) EPC Renewal fees already due  for an earlier application at the date  of filing a divisional application  are due on its filing, i.e . on 26 September 2022. These f ees and any renewal fee due within four months of filing the divisional application may be paid within that period without an additional fee , i.e. until 26 January 2023. "
                },
                {
                    "Answer": "D",
                    "Justification": "The invitation was received ten days after the mailing date , i.e. three days later than the seven days stipulated in Rule  80.6 PCT, so the period expires three days later than two months from the mailing date , that is, on 5 February 2023, which is a Sunday. The final date for responding is therefore  6 February 2023 (Monday). Legal basis Rule 80.6 PCT […] Irrespective of the date  on which such a document or letter  was mailed, if the applicant offers  to the national Office or intergovernmental organization  evidence which satisfies th e national Office or intergovernmental organization  that the document or letter  was received more than seven days after the date it bears , the national Office or intergovernmental organization  shall treat the period starting from the date  of the document or letter  as expiring later by an additional number  of days which is equal to the number  of days which the document or letter  was received later  than seven days after the date it bears . 3 Rule 80.5(i) PCT If the expiration of any period during which any document or fee  must reach a national Office or intergovernmental organization  falls on a day  […] on which such Office or organization is not open to the public  for the purposes of the transaction of official business  […] the period shall expire  on the next subsequent day on which [ no such  circumstance] exists . "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 54 bis(a) PCT A demand may be made at any time  prior to the expiration of whichever of the following periods expires later: (i) three months from the date of transmittal to the applicant of the international search report or the declaration referred  to in Article 17(2)(a) , and of the written opinion established under  Rule 43bis .1 [i.e. 10 September 2022 ( Sunday), extended to 12 September 2022 ]; or (ii) 22 months from the priority date  [i.e. 17 December 2022 ( Saturday), extended  to 19 December 2022 ]. Rule 80.5(i) PCT If the expiration of any period during which any document or fee  must reach a national Office or intergovernmental organization  falls on a day  […] on which such Office or organization is not open to the public  for the purposes of the transaction of official business [, the time limit  is extended to next  open day ]. "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 90.4(b) PCT [A] separate power of attorney  shall be submitted to either the receiving Office or the International Bureau , provided that, where a power of attorney  appoints an agent  under Rule 90.1(b) , (b-bis),  (c)  or (d)(ii) , it shall be submitted to the International  Searching Authority , the Authority specified for supplementary search or the International Preliminary Examining Authority , as the case may be. Rule 90.4(d) PCT [Any] receiving Office , any International Searching Authority , any Authority competent to carry out supplementary  searches, any International Preliminary Examining Authority  and the International Bureau may waive the requirement under  paragraph  (b) that a separate power of attorney be submitted  to it […]. Rule 90.4(e) PCT Where the agent or the common representative submits any notice of withdrawal […] , the requirement under paragraph (b)  for a separate power of attorney  shall not be waived under  paragraph (d) ."
                },
                {
                    "Answer": "C",
                    "Justification": "The designation of inventor  is not listed in Rule  159(1) EPC. Legal basis 4 Rule 159(1) EPC In respect of an international application under  Article 153, the applicant shall perform the following acts within thirty -one months from the date of filing of the application or, if priority has been claimed, from the priority date : (a) supply, where applicable, the translation  of the international application required under Article  1 53, paragraph  4; (b) specify  the application documents , as originally filed or as amended, on which the European gr ant procedure is to be based ; (c) pay the filing fee  provided  for in Article 78, paragraph  2; (d) pay the designation fee  if the period under  Rule 39 has expired earlier ; (e) pay the search fee , where a supplementary European sea rch report has to be drawn  up; (f) file  the request for examination provided  for in Article 94, if the period under  Rule 70, paragraph  1, has expired earlier; (g) pay  the renewal fee in respect of the third year provided for in Article 86, paragraph  1, if the fee has fallen due earlier under Rule 51, paragraph  1; (h) file, where applicable, the certificate of exhibition referred  to in Article 55, paragraph  2, and Rule 25. "
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis G 4/08 of the Enlarged Board of Appeal If an international patent application has been filed and published under the PCT  in an official language of the EPO, it is not possible, on entry into the European phase, to file a translation of the application  into another EPO  official language . Article 14(1) EPC, Article 14(3) EPC ( language of proceedings ) Rule 36(2) EPC : A divi sional application shall be filed in the language of the proceedings  of the earlier application . Euro -PCT Guide, Chapter  5, points 5.1.013 and 5.1.014 "
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis PCT contracting states  for which a regional patent  can be obtained via  the PCT (wipo.int ): A national patent can be obtained  for Italy in respect of international applications filed  on or after 1  July 2020.  Only a European patent can be obtained  for France and Lithuania. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Notice from the EPO dated 21 February 2013 concerning the request for early processing, OJ  EPO 3/2013, 156 ff It depends on the date on which early processing is requested  which further requirements stipulated in Rule  159(1) EPC must be complied  with, since the ( regular) time limits for paying the designation fee (Rule  39(1) EPC) and the renewal fee (Rule  51(1) EPC) and for filing the request fo r examination and paying the examination fee (Rule 70(1) EPC ) may not have expired on the date the request for early processing is filed . Therefore, if any of these time limits is  still running on that date , the request will be effective without the requir ements  concerned having been complied  with ( Article 153(2) EPC , Article 11(3) PCT ). Claims fees  can be paid up to expiry of the period under Rule  162(2) EPC . In the present case, the ( regular) time limits for paying the designation , examination and renewal fees  are still running . "
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, E -VIII, 8.1, A- IV, 1.1.1 Applicants may withdraw their application at any time as long as the application is pending . An application is pending up to (but  not including) the date that the European Patent Bulletin mentions the grant of the patent (OJ  EPO 2002, 112). "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines for Examination in the EPO , H-VI, 6, C-V , 10 Errors in publication occur where the content of the printed specification differs from the documents (Druckexemplar) transmitted to the applicant with the communication under  Rule  71(3) (Form 2004), if these documents form the basis of the decision to grant. The above errors in publication can be corrected at any time . "
                },
                {
                    "Answer": "B",
                    "Justification": "Statement A is not correct because Rule  56 does not apply to missing claims  (the application was filed in 2021, i.e. before the entry into force  of the new Rule  56a EPC ). Statement B is correct  (Rule  56(3) EPC ). Statement C is not correct  because it is not possible  to amend the claims before search (Rule  137(1) EPC ). Statement D is not a good solution because  the date of a priority claim  would precede the date of filing of the European patent application by more than twelve months . Legal basis 6 Rule 56(1) EPC If the examination under  Article  90, paragraph  1, reveals that parts of the description, or drawings referred to in the description or in the claims, appear to be missing, the European Patent Office shall invite the applicant to file the missing parts within two months . Rule 56(3) EPC If the missing parts of the description or missing drawings are filed  […] and the application claims priority of an earlier application, the date of filing shall, provided that the missing parts of the description or the missing drawings are completely contained in the earlier application, remain the date on which the requirements laid  down in Rule 40, paragraph  1, were fulfilled, where the applicant so requests and files , […]. Rule 137(1) EPC Before receiving the European search report, the ap plicant may not amend the description, claims or drawings of a European patent application unless otherwise provided ."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "B",
                    "Justification": "The statement that 'the time limit for replying to the communication expires on 17 April 2023' is incorrect. According to Rule 132 of the EPC, when a communication from an examining division sets a time limit for reply, this time limit runs from the date the communication was deemed delivered to the applicant or their representative. Under Rule 64(1) of the Rules of Procedure of the European Patent Office (RP OJ EPO), a communication is considered delivered two weeks after it was posted. The communication in question is dated 7 December 2022, and hence would be deemed delivered on 21 December 2022. A four-month time limit for replying to such a communication would expire on 21 April 2023, not 17 April 2023.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 1.6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_6_1.html\nSource: Guidelines for Examination in the EPO, C-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_3.html\nSource: Guidelines for Examination in the EPO, E-VIII, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_2.html\nSource: Guidelines for Examination in the EPO, C-VI, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vi_1_1.html\nSource: Guidelines for Examination in the EPO, C-V, 4.9, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_4_9.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to the Guidelines for Examination in the EPO, specifically F-II, 6.1, when a European patent application discloses nucleotide or amino acid sequences that are fragments or variants of prior-art sequences already publicly available, no sequence listing is required. This applies even if the sequence is used only once in an example and not claimed. Since the sequence in question is disclosed but does not form part of any claim (i.e., it is not essential for the claims), there is no obligation to file a sequence listing.\\n\\n**Why other options are incorrect:**\n- **Option A:** Incorrect because, as per F-II, 6.1, if sequences are fragments or variants of prior-art sequences and these do not form essential features of the claimed subject-matter (in this case, they're not part of any claim), there is no need to file a sequence listing even upon invitation from the EPO.\n- **Option B:** Incorrect because while failure to react to an invitation may lead to consequences for other procedural requirements, it does not apply here since no sequence listing was originally required due to the sequences being fragments or variants of publicly available sequences and not part of the claims.\n- **Option C:** Incorrect because even if a sequence listing is necessary (which it isn't in this case), according to E-IX 2.4.2, it must be submitted in electronic form, not PDF format.\\n\\nTherefore, option D accurately reflects the situation where filing a sequence listing is unnecessary for an amino acid sequence disclosed but not claimed and that is a variant of prior-art sequences.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, G-III, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iii_4.html\nSource: Guidelines for Examination in the EPO, A-IV, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_5.html\nSource: Guidelines for Examination in the EPO, F-III, 6.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_iii_6_4.html\nSource: Guidelines for Examination in the EPO, F-II, 6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_ii_6_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.4.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_4_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "According to the Guidelines for Examination in the EPO, H-VI, 3.1, Rule 140 is not available to correct errors in documents filed by a patent applicant or proprietor unless proceedings are still pending (seeH-VI, 2.1). Furthermore, once the decision to grant is handed over to the EPO's internal postal service, only specific types of errors may be corrected underRule 139: these include errors in bibliographic data, printing errors in the publication of the patent specification, and formatting/editing errors (seeH-VI, 3.2andH-VI, 3.3). Hence, any typographical error in claim 1 can only be corrected prior to this handover point. The date of publication of the mention of grant is too late because corrections underRule 139 are no longer possible once the patent has been granted and published (Choice B), Notification of the decision to grant comes after the document is handed over internally within the EPO, making it past the point for correction according to the guidelines (Choice C), The communication under Rule 71(3) EPC pertains to a specific stage during examination proceedings but does not set the final deadline for correcting errors underRule 139 (Choice D).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_v_3.html\nSource: Guidelines for Examination in the EPO, H-VI, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_4.html\nSource: Guidelines for Examination in the EPO, A-VII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_7.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, H-VI, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "According to the Patent Cooperation Treaty (PCT), an international patent application can be filed with the International Bureau of WIPO by any individual or entity that meets the requirements for filing a PCT application. There is no requirement in the PCT system that limits filing to specific nationalities or geographical locations, as long as the formal requirements are met. Antonia can validly file an international patent application (PCT-A) with the International Bureau of WIPO. Option B incorrectly states that the EPO handles international patent applications under the PCT, which is not true since the EPO is involved in the European Patent System (EPC). Option C correctly states that a European patent application can be filed with the EPO but focuses on EP-A rather than the correct international filing under PCT. Option D incorrectly suggests that Antonia cannot file a PCT application with WIPO, which contradicts the facts presented.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "To determine which statements are correct concerning renewal fees for EP-X and EP-Y, each statement is analyzed in detail. **Statement I** incorrectly specifies the exact dates for when renewal fees are due. **Statement II** correctly indicates that renewal fees can be paid within the grace period with or without an additional fee based on Rule 58(4) EPC. Therefore, only Statement II adheres to the legal requirements and is correct. Other options (A, C, D) are incorrect as they either incorrectly assert the accuracy of Statement I or misrepresent the correctness of Statement II.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to Rule 67(1)(a) of the PCT and Rule 259(c)(i) of the European Patent Convention (EPC), when an invitation by a designated Office, such as the EPO acting as the Receiving Section for an international patent application, specifies a time limit for a response, this period begins to run from the date on which the communication is received. The applicant's receipt date can be evidenced by the mail service stamp on the communication. Therefore, if the invitation was dated 2 December 2022 and received on 12 December 2022 with the postal service stamp confirming this receipt date, the two-month period to respond would begin from 13 December 2022. The end of a two-month time limit is calculated as follows: starting from 13 December 2022 and counting exactly two months (i.e., adding 60 days), we arrive at 13 February 2023. However, since the deadline falls on the 13th, this date itself would be the final day to respond as per standard time limit calculation rules. Hence, the final date for responding to the invitation is 5 February 2023 (one day prior to 6 February 2023), but in strict compliance with the exact end of the period, it is more accurate to consider the last working day before 13 February 2023. However, given the options provided and adhering strictly to legal interpretations: Option A (2 February 2023) would be too early; Option B (13 February 2023), while technically correct for a two-month period, is not typically an option in this kind of strict adherence to EPO practice due to the last working day rule. Option C (5 February 2023), though one day less than the calculated end date considering practical constraints and adjustments, aligns with standard practices and legal context. Option D (6 February 2023) would be incorrect since it is an additional day beyond the computed period which typically adheres to the last working/business day rule. Therefore, Option C correctly reflects the final response deadline based on standard procedural practices within the EPO's framework for such deadlines.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, C-II, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_1.html"
                },
                {
                    "Answer": "The last day for filing a demand for international preliminary examination is 10 September 2022.",
                    "Justification": "According to PCT Rule 65(1), the deadline for filing a request for an international preliminary examination is three months from the date on which the international search report and written opinion are transmitted by the International Searching Authority. Given that the transmission of these documents occurred on 10 June 2022, the demand must be filed within three months, landing us on 10 September 2022.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, B-XI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_xi_2.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 4.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4_1.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to the Guidelines for Examination in the EPO, particularly regarding actions at different stages of patent proceedings under the PCT framework: Withdrawing an international application at the European Patent Office as receiving office (I) can be done by a professional representative who has been duly appointed with proper authorization. While a power of attorney is typically required for representation, exceptions exist where such documentation may not strictly be necessary if other equivalent evidence substantiating authority to act on behalf of applicants is provided. Filing a demand for international preliminary examination at the EPO as an International Preliminary Examining Authority (II) can similarly be handled by a professional representative under appropriate authority. The necessity of a power of attorney in this case may also be waived under certain circumstances, such as when equivalent documentation or legal standing is established. 1. **Why Other Options Are Incorrect:** A: This statement is incorrect because it implies that a signed power of attorney by each applicant is always required for both actions, which is not accurate since exceptions and equivalents are allowed. B: While partially true (a signed power of attorney from each applicant might typically be expected in the context of withdrawing an application), this option incorrectly suggests exclusivity. It does not account for scenarios where such documentation can be waived or substituted. C: Similarly, while a power of attorney could generally be required for filing demands for international preliminary examination, this statement is overly definitive without recognizing possible exceptions under which a formal signed power of attorney might not be strictly necessary.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VIII, 1.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_8.html\nSource: Guidelines for Examination in the EPO, A-IV, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_6.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-II, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_2.html\nSource: Guidelines for Examination in the EPO, A-VIII, 1.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_5.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to the Guidelines for Examination in the EPO (E-IX, 2.1.1), the acts required for entering into the European phase include supplying a translation if necessary, specifying application documents, and paying various fees such as the filing fee and designation fees, but there is no mention of designating an inventor. Option A involves supplying a translation when needed, Option B requires specifying the application documents, and Option D pertains to paying certain fees under specific conditions, whereas Option C is not among the acts necessary for entering into the European phase.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, G-IV, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iv_5_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_2.html\nSource: Guidelines for Examination in the EPO, B-III, 3.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_iii_3_3_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_1.html\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "The correct option C states that upon entry into the European phase with EPO Form 1200, the applicant can select English as the language of the proceedings. According to Rule 6(3) in conjunction with Article 14(4), applicants may file documents in a non-official EPO language if they qualify based on their nationality or place of business within a contracting state whose official language is that used by the applicant. If one of these conditions applies, the language selected during entry into the European phase will be used for subsequent proceedings, as per Rule 6(3). Option A is incorrect because according to Article 14(1), upon entering the European phase, any translation into English must be filed simultaneously with the document 'as filed,' and the rules do not explicitly provide an opportunity to change languages post-entry merely by filing a translation. Option B is also incorrect. While it’s true that once an international application enters the European phase, it can lead to European patent applications or divisional applications in different official EPO languages, Rule 6(3) does not permit changing the language of proceedings for a divisional application from the original language selected at entry into the European phase (in this case French). Option D is incorrect because option C accurately reflects the applicable legal provisions. Therefore, under the correct legal context and as per the guidelines provided in the EPO rules, only option C correctly describes how an applicant can choose English as the language of proceedings upon entering the European phase.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html"
                },
                {
                    "Answer": "D",
                    "Justification": "The question pertains to entering the national phase directly from an international patent application filed in 2021. The countries listed—Lithuania, France, and Italy—are not relevant under the provided Guidelines for Examination in the EPO, specifically sections A-IV and A-VII, which deal with European patents rather than entering national phases directly from international applications. For an international patent application filed under the PCT, direct entry into the national phase occurs by designating countries that are part of the PCT system, not through conversion processes within the EPC framework as per Article 135. Therefore, given these guidelines and the context provided, option D (None of the above) is correct.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-IV, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_6.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Article 23(2) PCT and the EPO's Implementing Regulations, early entry into the European phase requires payment of certain fees. Specifically, when a PCT application enters the European phase via early entry, it must include the filing fee (Art. 160 PCT), claims fees for each claim beyond the initial 20 (Rule 70.3(a) PCT实施细则), and any other applicable fees as per Rule 70.5(c)(i). The International Patent Application PCT-1 has 17 claims, which is below the threshold requiring additional claims fee. However, the filing fee must still be paid.\\n\\nPayment of only the filing fee (A) is insufficient as Article 23(2) mandates that in addition to the filing fee, claims fees should also be paid for each claim beyond the initial limit if applicable. Including payment of the examination fee, renewal fee, and designation fee (C) is not required at this stage. These are additional requirements typically needed during other procedural phases or specific steps in patent application processing but not specifically called out by Article 23(2). The examination fee is not a prerequisite for early entry into the European phase under Article 23(2) PCT; it will be due at later stages of proceedings. Similarly, payment of designation fees and the filing fee alone are insufficient without claims fees as required.\\n\\nHence, according to PCT and EPO regulations, valid early entry requires both the filing fee and any applicable claim fees for each claim over 20 (though in this case there aren't more than 20), making Option B correct.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 11.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_11_2_5.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, H-II, 2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_2_1.html"
                },
                {
                    "Answer": "The latest of the date of payment of the fee for grant and publishing, and the date of filing of the translations of the claims in the two other official languages of the EPO.",
                    "Justification": "According to Rule 71(3) EPC, an application can be withdrawn at any time before a communication under Rule 71(3) is received. Once such communication has been issued and assuming the applicant does not withdraw earlier, the latest point in time for effective withdrawal is when the application reaches its final stages towards grant, including both payment of the grant fee and filing of the necessary translations required by EPC. Option B correctly identifies that the application can be withdrawn up to the latest occurrence between: The date on which the fee for grant has been paid; The date when the translations of claims in two official languages (other than the language of publication) have been filed; And the date by which the mention of the grant is published in the European Patent Bulletin. Options A, C, and D are incorrect because they either refer to points after effective withdrawal is no longer possible or suggest arbitrary deadlines without specific legal backing.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, A-III, 11.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_11_2_5.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to J 14/87 (OJ 1988, 295), a deficiency such as an omission in the publication of the patent specification does not necessarily render the decision to grant ineffective. However, any correction must be handled with care due to the importance of the published information for interested parties and the need for accurate examination during opposition proceedings. The purpose of publishing the mention of grant and the full text of the patent is twofold: first, it draws attention to the new patent status so that interested third parties can examine the extent of protection conferred by the patent. Second, any decision regarding filing an opposition needs a thorough review of all published details. During the opposition period or if opposition proceedings are pending, alterations could potentially prejudice the rights of those involved in such proceedings. Other options are incorrect because: Answer A ignores possible correction under certain circumstances; Answer B overlooks critical timing constraints; and Answer D misinterprets when corrections can be made.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, H-VI, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_5.html\nSource: Guidelines for Examination in the EPO, B-XI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_xi_2.html\nSource: Guidelines for Examination in the EPO, C-V, 10, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_10.html\nSource: Case Law IV, B.3.11, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_b_3_11.html\nSource: Guidelines for Examination in the EPO, H-II, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_3_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "Based on the Guidelines for Examination in the EPO and Article 123(2), an applicant may file missing parts of a European patent application at any time up to the end of the six-month period following the date of filing, without affecting the filing date. According to Rule 68(4) EPC, if a part of the content is inadvertently omitted when filing, it can be added within this period without altering the original filing date. In the provided scenario: - The European patent application EP-A was filed on 27 October 2022. - Missing parts (page 3 of description and claims 7-12) were identified on 3 November 2022, which is within the six-month period after filing. Therefore, the applicant may file these missing parts without the application being re-dated. The end of the six-month period would be 2 January 2023 (six months from 27 October 2022). Other options are incorrect because: - **Option A:** Incorrect because while it is true that the EPO can invite to file missing parts, under Article 123(2) and Rule 68(4), the applicant has an automatic right to do so at any time within six months of filing without needing to wait for such an invitation or a two-month time limit. - **Option C:** Incorrect because while claims can be added if their subject-matter is in the description, this must still adhere to Rule 68(4), i.e., it should be done within six months from filing. It does not imply that missing claims can be added at any point without a time limit. - **Option D:** Incorrect because withdrawing and re-filing the application would result in losing the priority date since FR-A was filed on 29 October 2021, making it impossible to claim valid priority if refiling occurs after this window. Furthermore, Article 87(4) EPC allows rectification of clerical errors within six months without invalidating the priority.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, F-III, 6.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_iii_6_4.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: Guidelines for Examination in the EPO, E-VIII, 4.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4_1.html\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html\nSource: Guidelines for Examination in the EPO, A-III, 9, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_9.html"
                }
            ]
        },
        {
            "filename": "2023_EPAC_mcq.json",
            "questions": [
                {
                    "question": "A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?",
                    "options": [
                        "A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .",
                        "B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .",
                        "C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .",
                        "D. Ms Smith can only be deleted as inventor with her consent ."
                    ]
                },
                {
                    "question": "On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?",
                    "options": [
                        "A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .",
                        "B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .",
                        "C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.",
                        "D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant ."
                    ]
                },
                {
                    "question": "EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?",
                    "options": [
                        "A. T ime limit for pay ing the designation fee",
                        "B. T ime limit for requesting examination",
                        "C. T ime limit for filing the application within the priority period",
                        "D. T ime limit for paying the fee for re- establishment of rights"
                    ]
                },
                {
                    "question": "Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?",
                    "options": [
                        "A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.",
                        "B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.",
                        "C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.",
                        "D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney."
                    ]
                },
                {
                    "question": "In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.",
                    "options": [
                        "A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .",
                        "B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.",
                        "C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.",
                        "D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian."
                    ]
                },
                {
                    "question": "Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?",
                    "options": [
                        "A. The deficiency cannot be remedied.",
                        "B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .",
                        "C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.",
                        "D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights."
                    ]
                },
                {
                    "question": "On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \" Decision to grant a European patent pursuant to Article  97(1) EPC \". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?",
                    "options": [
                        "A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.",
                        "B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.",
                        "C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .",
                        "D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest ."
                    ]
                },
                {
                    "question": "During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?",
                    "options": [
                        "A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.",
                        "B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.",
                        "C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.",
                        "D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months."
                    ]
                },
                {
                    "question": "Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?",
                    "options": [
                        "A. 18 months from the earliest priority date",
                        "B. 30 months from the earliest priority date",
                        "C. 22 months from the earliest priority date",
                        "D. 26 months from the earliest priority date"
                    ]
                },
                {
                    "question": "After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?",
                    "options": [
                        "A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn",
                        "B. Form 1226BB offering the opportunity to comment and file amendments",
                        "C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up",
                        "D. Form 1226AC stating that the examination has started"
                    ]
                },
                {
                    "question": "Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?",
                    "options": [
                        "A. The applicant can choose the EPO as ISA and the USPTO as IPEA.",
                        "B. The applicant can choose the USPTO as ISA and the EPO as IPEA.",
                        "C. The applicant can choose the Austrian Patent Offic e as ISA and the",
                        "EPO as IPEA.",
                        "D. The applicant can choose the EPO as ISA and the Intellectual Property",
                        "Office of Singapore as IPEA."
                    ]
                },
                {
                    "question": "On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?",
                    "options": [
                        "A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.",
                        "B. Yes, the time limit for adding the priority claim expires on 7  November 2023.",
                        "C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.",
                        "D. No, the time  limit for adding the priority claim expired on 3 July 2023."
                    ]
                },
                {
                    "question": "The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?",
                    "options": [
                        "A. The opponent/ respondent needs  to request an extension of the period for comment.",
                        "B. The opponent/respondent needs to pay a fee for further processing.",
                        "C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.",
                        "D. None of the above."
                    ]
                },
                {
                    "question": "A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?",
                    "options": [
                        "A. As no renewal fees have been paid, the application is deemed to be withdrawn .",
                        "B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .",
                        "C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .",
                        "D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest ."
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "D",
                    "Justification": "Legal basis A n incorrect designation of inventor shall be rectiﬁed upon request and only with the consent of the wrongly designated person and, where such a request is ﬁled by a third party, the consent of the applicant for or proprietor of the patent (R. 21(1) EPC)."
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis R epresentative X is a representative according to article 134.1 EPC and is already registered as representative for the European patent application EP -A, so any registration of change in representation by a new European patent atorney necessitates an authorization for representation signed by the applicant to be validly registered by the EPO. According to rule 152(1) EPC, The President of the European Patent Offi ce shall determine the cases in which a signed authorization shall be ﬁled by representatives acting before the European Patent Office. In decision of the President of the EPO of 12.07.2007 on the ﬁling of authorizations (Special edition No. 3, OJ EPO 2 007, L.1), (2) If the European Patent Office is informed of a change of representative involving professional representatives who are not members of the same association, without being notiﬁed that the previous representative's authorization has terminate d, the new representative must ﬁle, together with the notiﬁcation of his appointment, an individual authorization (original and one copy) or a reference to a general authorization already on ﬁle If an authorization for representation is not provided, an y acts done by the “new” representative will be deemed to never have occurred by the EPO. R 152(6) Representative Y shall ﬁle a change in representation with form 5060 to register before the EPO as the new representative, an authorization of representatio n signed by the applicant for the change in representation to be valid and a response to the writen opinion before the EPO before: T ime limit to respond to the negative search opinion: publication  date  of the EESR: 12 April 2023 + 6 months (R 70a(1) + R  70(1) EPC) = 12 October 2023  (Tuesday) 2"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Ac cording to Art. 122 EPC and Rule 136(1) EPC it is possible to obtain re -establishment of rights in respect of the priority period (twelve months according to Art. 87(1)  EPC). A : Rule 136(3) EPC: Further processing is available B: Rule 136(3) EPC: Further processing is available D: Article 122(4) EPC Re -establishment of rights shall be ruled out in respect of the time limit for requesting re-establishment of rights Question 4 : B Legal basis Rule 90.4(d) PCT Subject to paragraph (e), any r eceiving Office,  any International Searching Authorit y, any Authority c ompetent to carry o ut supplementary s earches,  any I nternation al Preliminary Examining Authority a nd the International Bureau may waive the requ irement under paragraph (b) tha t a separate power o f atorney be submited to it, in which case paragraph (c) shall not appl y. Question 5 : D Legal b asis Art. 14(4) EPC: “Natural or legal persons having their residence or princip al place of business within a Contracting State  having a language othe r than English, French or German as an offic ial language, and nationals of that State  who are resident abroad, may ﬁle documents which have to be ﬁled within a time limit in an offic ial language of that State .” Article 14(1) RFees : 30% reduction of the application fee; Rule 6 RFees A-X, 9.2.1; A-X, 9.2.2 A-X, 9.2.1 Conditions - Guidelines for Examinatio n (epo.org) A-X, 9.2.2 Reduction o f the ﬁ ling f ee - Guidelines for Examination (epo.org) Notice from t he EPO date d 10 January 2014 concerning amended Rule  6 EPC an d Article 14(1 ) RFees ( EPO - Notice f rom t he E PO d ated 1 0 January 2014 concerning amended Rule 6 EPC and Article 14(1 ) RFees ) A. Not c orrect ( Andorra i s not an EPC contracting state); A rt. 14(4) E PC relates t o the applicant and not to his representative) 3 B. Not correct (the German company is not considered as SME - R. 6(4)a, R. 6(7) // Notice from the EPO dated 10 January 2014 concerning amended Rule 6 EPC and Art. 14(1) RFEES) C. Not correct (French is an official language of the EPO  Art. 14(1) EPC ) D. Correct (applicant of an EPC contracting state with resident abroad; Italian is official language of Switzerland ; natural person is entitled to the reduction )"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 90.4(d) PCT Subject to paragraph (e), any receiving Office, any International Searching Authority, any Authority competent to carry out supplementary searches, any International Preliminary Examining Authority and the International Bureau may waive the requirement under paragraph (b) that a separate power of attorney be submitted to it, in which case paragraph (c) shall not apply."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Art. 14(4) EPC: “Natural or legal persons having their residence or principal place of business within a Contracting State having a language other than English, French or German as an official language, and nationals of that State who are resident abroad, may file documents which have to be filed within a time limit in an official language of that State.”"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis R36(2), R135(2) EPC The English translation of the application documents must  be ﬁled within 2 months of ﬁling the DA. If the English translation is not ﬁled: The EPO will issue  a communication pursuant to  Rule 58 EPC seting a time limit of further 2 months for ﬁling the  translation. If the English translation is not ﬁled within the time limit set by the communication pursuant Rule 58 EPC: a loss of rights communication is issued: f urther processing is ruled out for  the missing 2 -month time limit of Rule 58 EPC  -> re-establishment of rights ."
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Art 86 EPC, Rule 51 EPC, Art 141 EPC Due date of the renewal fee: 30 November 2023 = atier grant of the patent renewal fee must be paid to the national offices. Time limit: 2 months of publication of grant in the European Patent Bulletin: 8 January 2014"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines D- VI, 7.2.3 A: incorrect because of the entire description B: correct C: incorrect ; the invitation  is not  issued  together  with  the interlocutory  decision , but atier the interlocutory  decision  has become  ﬁnal and can no longer  be appealed D: incorrect: 3 months is correct Rule 82(2)  EPC 4"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis R 91.2 PCT : the time limit for ﬁling a request for rectiﬁcation of an obvious mistake is 26 months from the earliest priority date"
                },
                {
                    "Answer": "C",
                    "Justification": "(the most correct answer), D (also possible) Legal basis A rt. 121(1) (2), Rule 135(1) and (3) EPC, Art. 2(1), item 12 RFees Guidelines for Examination E -VIII, 2 (Further processing) and E -VIII, 3.1.3 E-IX, 2.3.1 (Representation, address for correspondence) Comment: A good paralegal will perform all acts of C, including  the appointment of the representative. H owever , formally/grammatically D can also be considered as a correct answer to the question,  because the appointment of the professional representative can be done later (if the translation is supplied and the fees are paid, but no professional representative has been appointed, the JP applicant may be invited to appoint a professional representative under R 163(5) EPC. The procedural acts of requesting examination and filing the translation could also be c onsidered as unsigned documents, because the JP applicant is not entitled to sign.   He might receive an invitation under R 50(3) EPC to supply a missing signature, which can be fulfilled by appointing a professional representative."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis G uide for applicants: PCT procedure before the EPO (Euro -PCT Guide) - 5.4 Amending the application - Rule 161/162 communication G uidelines for examination GL E -IX, 2.1.1 ( 2.1.1 Requirements for entry into the European phase (epo.org) ) E-IX, 3.3.1 ( htps://www.epo.org/law -p ractice/legal- texts/html/guidelines/e/e_ix_3_3_1.htm ) 5 “A reply to the communication under Rule 161(1)  may not be necessary … If the applicant ﬁled amendments according to Art. 19  and/or 34 PCT  in the international phase, and if the EPO prepared the WO -ISA or SISR but no IPER (either because the applicant did not demand PCT Chapter II  or because the IPEA was an office other than the EPO), then these amendments are considered to constitute a response to the WO -ISA or SISR, provided that the applicant has indicated on entry into the European phase that these amendments are maintained…”"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Explanation: Applicant's Guide - MX - Annex C - Receiving Office PCT Applicant's Guide Mexico - Valid as from 13 Apr 2023 (wipo. int) Competent International Searching Authority: AT, CL, EP , ES, KR, SE, SG, US Competent International Preliminary Examining Authority: AT, CL*, EP**, ES, KR, SE, SG*, US* * The Office is competent only if the international search is or has been carried out by that Office. ** The Office is competent only if the international search is or has been carried out by that Office, the Austrian Patent Office, the Spanish Patent and Trademark Office or the Swedish Intellectual Property Office (PRV)."
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis PCT Rule 26 bis.1 (a), stating : “The applicant may correct a priority claim or add a priority claim to the request by a notice submited to the receiving Office or the International Bureau within a time limit of 16 months from the priority date or, where the correction or addition would  cause a change in the priority date, 16 months from the priority date as so changed, whichever 16 -month period expires ﬁrst, provided that such a notice may be submited until the expiration of four months from the international ﬁling date.” 6 Questio n 14: D Legal basis A n extension must be requested before expiry of the period for responding not the case here. Further processing is only available to applicants (and thus before grant). The non- observance of the time limit to ﬁle comments does not have the direct consequence demanded for re -establishment of rights in Art 122(1). [see G1/90] Therefore, only D can be correct,  and the Board will exercise its discretion. The Opponent/Respon dent should thus submit reasons for submiting them late."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis An extension must be requested before expiry of the period for responding not the case here. Further processing is only available to applicants (and thus before grant). The non-observance of the time limit to file comments does not have the direct consequence demanded for re-establishment of rights in Art 122(1). [see G1/90] Therefore, only D can be correct, and the Board will exercise its discretion. The Opponent/Respondent should thus submit reasons for submiting them late."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines, E -Vii.1.5 Concerning renewal fees falling due during the period of interruption, Rule 142(4) has to be interpreted as deferring the due date for their payment until the date the proceedings are resumed (J 902/87). Thus, such renewal fees may be paid without additional fee at the date of resumption and in the amounts applicable on that date. They may also be paid within six months of said date, provided that an additional fee is also paid within said period (Rule 51(2))."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "D",
                    "Justification": "According to EPC Rule 60 and the Guidelines for Examination in the EPO (A-III, 5.2), once a European patent application is published or granted, inventors can send a written waiver of their right to be mentioned as an inventor after publication. This means that Ms Smith, who was erroneously designated as an inventor, could waive her rights under Rule 143(1)(g) and Rule 144(c). However, the EPC does not explicitly state or allow for unilateral correction by the patent proprietor without the consent of the person involved unless it falls under a specific procedural error that can be corrected under EPC Articles such as Article 126 (Rectification procedure). Since there is no active opposition proceeding here and no provision allowing correction of inventorship unilaterally, Ms Smith’s name will only be deleted from the patent if she consents to this change by submitting a written waiver. Therefore, Ms Smith can only be deleted as an inventor with her consent.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, D-I, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_i_6.html\nSource: Case Law III, Q.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_1.html\nSource: Guidelines for Examination in the EPO, H-II, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_3_2.html\nSource: Guidelines for Examination in the EPO, A-III, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_5_2.html\nSource: EPC Rule 60, Url: https://www.epo.org/en/legal/epc/2020/r60.html"
                },
                {
                    "Answer": "D",
                    "Justification": "The correct course of action for new representative Y involves several key steps that must be carefully followed to ensure there is no loss of rights and to validly appoint Y as the new representative. According to Article 133(1) EPC, a change of representation requires an authorization signed by the applicant (or his successor in title) to be filed with the EPO within one month from the communication of the change to the former representative or without delay if this cannot reasonably be done.\\n\\nIn the given scenario, X is unaware that Y will replace him. Therefore, X must first be informed of the change by the applicant (who can communicate directly or through Y). According to Rule 37(2) EPC, a request for a change of representation needs to be submitted promptly after informing the former representative.\\n\\nNext, according to Rule 40(1), any response to the extended European search report must be filed within two months from the date on which it was mailed out (hereby calculated as 6 April 2023 + 2 months = until 7 June 2023). However, if a request for change of representation has been made, Rule 40(5) states that any deadline based on communication with the former representative is suspended and re-calculated from the new representative. Since Y was appointed after the extended European search report issuance but before its deadline, it must be filed by the revised date considering the suspension period until October (the period of time between the filing of the change request to representation).\\n\\nConsidering Rule 135(2), if the authorization is not provided within a reasonable time frame or without delay following the notification, rights may be lost. Therefore, new representative Y should file an authorization signed by the applicant in good time alongside the other actions.\\n\\nThe correct answer D captures these steps: \\n- Requesting a change of representation.\\n- Filing a response to the extended European search report with the EPO within two months from when X was notified and one month after filing the request for change (by 12 October 2023, revised deadline).\\n- Ensuring an authorization signed by the applicant is filed promptly alongside.\\n\\nOptions A, B, and C are incorrect because:\\n- Option A: Does not emphasize the requirement of 'in good time' filing an authorization signed by the applicant.\\n- Options B and C: Ignore the need to file the authorization in a timely manner as per Rule 135(2).\\n\\nTherefore, D is the only comprehensive option that covers all required aspects to ensure there's no loss of rights while validly appointing representative Y.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, B-XI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_xi_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, H-II, 2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_2_1.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, E-VIII, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Article 122 of the EPC and Rule 136, re-establishment of rights can be requested if a missed time limit results in adverse consequences, such as loss of rights. In this case, failing to request examination within the specified period may lead to the application being deemed withdrawn, which is an adverse consequence that can be remedied through re-establishment. The other options are incorrect because: A (Time limit for paying the designation fee) - Rule 135(2) specifically rules out further processing for a missed designation fee payment; C (Time limit for filing the application within the priority period) - The priority date is fixed and cannot be altered or re-established under EPC provisions, meaning missing this deadline means losing the benefit of the earlier filing date with no remedy via re-establishment according to Article 122; D (Time limit for paying the fee for re-establishment of rights) - This option is self-referential and nonsensical in this context because requesting re-establishment itself does not have a separate time limit fee that could be missed.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-III, 11.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_11_2_5.html\nSource: Guidelines for Examination in the EPO, E-VIII, 3.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_3_1_1.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "This statement is incorrect because under the Patent Cooperation Treaty (PCT), the demand for international preliminary examination can be filed and signed by a representative appointed by the applicant, even if they are not a European patent attorney as long as they have authorization from the applicant to act on their behalf before the International Bureau of WIPO. In this case, Hassan is entitled to represent Greta before the DPMA (German Patent and Trade Mark Office), which suggests he has such authority. However, signing demands for international preliminary examination does not necessarily require him to be a European patent attorney.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-II, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_2.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Rule 6 EPC, a reduction of the filing fee applies to applicants who meet certain criteria. Specifically, if an applicant is: 1) A natural person resident in one of the Contracting States (Article 4(1) of the European Patent Convention, EPC); or 2) A legal entity or other body equivalent to a legal person by virtue of the law governing it, whose principal place of business or effective headquarters are situated in one of those states. In option B: - A firm with its principal place of business in Germany and a natural person resident in Germany file a European patent application. - The natural person's nationality (Dutch) does not affect eligibility as per Rule 6 EPC, which focuses on residency. Thus, the applicant here is eligible for the fee reduction because he/she meets the condition of being resident in one of the Contracting States. **Explanation for Incorrect Choices:** - A: While a natural person from Andorra can file an application and reside there, the specific requirement under Rule 6 EPC is that the principal place of business (for legal entities) or residency must be within a Contracting State. As Andorra may not necessarily qualify as such under EPC Article 4(1), this option doesn't fit the eligibility criteria for fee reduction. - C: The applicant is resident in the USA and has Belgian nationality, both of which are outside the scope of Rule 6 EPC requirements since the rule applies to specific Contracting States only. Hence, no filing fee reduction can be granted here. - D: Similarly to option C, the applicant is resident in the USA with Swiss nationality, not fulfilling the requirement that residency must be within a Contracting State for fee reduction eligibility under Rule 6 EPC. Therefore, only option B meets the specific conditions required by Rule 6 EPC to qualify for a reduced filing fee.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-IV, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_6.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-II, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Article 14(2) of the European Patent Convention (EPC), for an application filed in a language other than one of the official EPO languages, a translation into an official language must be submitted. The guidelines allow correction of any errors or deficiencies at any time during pre-grant and opposition proceedings as long as it does not contravene Article 123(3) (i.e., extending protection beyond what was originally claimed). Therefore, Mr Van Holland can remedy the deficiency by filing an English translation of EP-div within a reasonable period. Typically, this is done within two months of notification under Rule 112(1), which allows applicants to rectify deficiencies.\\n\\nOption A: Incorrect because it's not true that the deficiency cannot be remedied. As per the guidelines and Article 14, corrections can be made at any time before grant if they are within the scope of what was originally filed.\\n\\nOption C: Incorrect because there is no need to file a request for further processing as per Rule 76(a) EPC, which allows amendments directly without additional procedural requests in most cases. The deficiency should simply be corrected by filing the translation.\\n\\nOption D: Incorrect because re-establishment of rights (Rule 136 EPC) is typically used to remedy loss of rights due to failure to observe prescribed time limits, and not for correcting deficiencies like translations. Since Mr Van Holland has already paid fees and only needs to file a translation, this option would be unnecessary.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-VII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_7.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to Rule 71(2), renewal fees for European patents must be paid separately in each designated contracting state where validation is sought. Additionally, under Article 94(3) and Rule 88(3)(c), the due date for paying renewal fees for any year following the fourth year after filing (in this case, the fifth year) starts from the day after the publication of the European patent bulletin mentioning grant. The grant communication was received on October 12, 2023; however, the effective payment period begins only once the actual mention in the European Patent Bulletin is published.\\n\\nThe fourth-year renewal fee, due before the end of the third year from filing (i.e., by November 15, 2023), must be paid centrally to the EPO without any additional validation fees. For subsequent years following grant, including the fifth year (beginning on November 16, 2023 and due before April 16, 2024), renewal fees must be paid separately in each state of validation.\\n\\nGiven that payment deadlines are generally two months from the effective date for valid filing without additional late-payment fees, the deadline to pay the fifth year's renewal fee (after grant) is extended until January 16, 2024. Therefore, Option D correctly states this condition.\\n\\nWhy other options are incorrect:\\n- **Option A:** Incorrect because payment must be made separately in each state and not centrally after grant.\\n- **Option B:** This option discusses the fourth-year renewal fee which is due centrally by November 15, 2023 (not November 30), before validation.\\n- **Option C:** The date mentioned for valid filing without a late-payment fee is incorrect as it does not account for the grace period until January 16, 2024 after grant publication.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to the Guidelines for Examination in the EPO as referenced, when a decision is made during opposition proceedings to maintain the European patent in amended form, the decision must be delivered. The decision will specify that the patent proprietor needs to take certain steps following delivery of this interlocutory decision. These steps include paying the fee for publishing a new specification, filing translations of the claims (if necessary), and ensuring that any formally non-compliant amendments are corrected. In the scenario where a paragraph in the description is amended with handwritten changes, it would be incumbent upon the patent proprietor to make these corrections before the patent can proceed to publication. Thus, option C correctly states that together with delivering the interlocutory decision, an invitation will accompany this requiring the patentee to rectify these formalities. Why other options are incorrect: Option A is incorrect because according to EPO practice (as mentioned in D-VI, 7.2.2), it's not upon request but as a matter of procedure that the corrected version and fees must be submitted; hence this option inaccurately implies an optional nature for fulfilling these requirements. Option B misrepresents the process by incorrectly stating that appeals would automatically suspend any actions required by the patentee following a decision to maintain a patent in amended form. In fact, as per EPO practice, such actions need to follow irrespective of whether an appeal is filed and remain pending, unless there are specific procedural instructions provided due to an ongoing appeal. Option D inaccurately suggests that these steps will only be requested upon filing a request by the patentee and also incorrectly mentions a four-month period which isn't directly stated as binding or mandatory without context in EPO guidelines. The correct timing is part of the standard procedure following interlocutory decision delivery.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, H-II, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_3_2.html\nSource: Guidelines for Examination in the EPO, H-VI, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_5.html\nSource: Guidelines for Examination in the EPO, H-II, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_3_1.html\nSource: Guidelines for Examination in the EPO, D-VI, 7.2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vi_7_2_2.html\nSource: Guidelines for Examination in the EPO, D-V, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_v_5.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Article 19(2)(a) and Rule 40(1) of the Patent Cooperation Treaty (PCT), the time period for requesting rectification is within 16 months from the earliest priority date or filing date if no priority claim has been made. Since option B states a timeframe closer to this period, it’s chosen as the most relevant among the given options. The other options are incorrect because they either provide longer periods that exceed the allowable limit of 16 months under PCT rules.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, G-IV, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iv_5_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_2.html\nSource: Guidelines for Examination in the EPO, B-III, 3.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_iii_3_3_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.11, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_11.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to the Guidelines for Examination in the EPO and Rule 161(2), upon entry into the European phase with a European application that has been amended under Article 19 PCT, the applicant is given an opportunity to file further amendments within a set time limit. This is typically communicated using Form 1226BB, which offers the applicant the chance to comment and submit additional amendments before proceeding any further in the examination process.\\n\\nWhy other options are incorrect:\\n- Option A: Form 1226AA would be used if there was no opportunity for the applicant to file further amendments (i.e., when entering with original application documents or an ISR/SISR without amendments). Since amendments were filed under Article 19 PCT, this form is not appropriate.\\n\\n- Option C: While it’s true that a supplementary European search might be required if there are no prior ISR or SISR to rely on (and hence the opportunity to file further amendments before such a report), here an amendment was already made during the international phase. Therefore, Form 1226CC is not applicable because a written opinion from the ISA has been issued and amendments were filed in response.\\n\\n- Option D: Form 1226AC would be used if examination could proceed immediately upon entry into the regional phase without any need for further amendment opportunities or supplementary searches. However, since the application was amended after receiving a negative written opinion, there's a requirement to file further amendments under Rule 161(2) before proceeding with substantive examination. Therefore, this form is not applicable here.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, C-III, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_iii_2_2.html\nSource: Guidelines for Examination in the EPO, C-II, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_3_2.html\nSource: Guidelines for Examination in the EPO, C-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_3.html\nSource: Guidelines for Examination in the EPO, B-III, 3.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_iii_3_3_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_3_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to the Guidelines for Examination in the EPO, an international patent application filed under the Patent Cooperation Treaty (PCT) can have different roles assigned to various national and regional offices, including being a receiving office, International Searching Authority (ISA), and International Preliminary Examining Authority (IPEA). The applicant has some discretion over which entities fulfill these roles as long as they comply with the rules set out in the PCT. Option B is correct because under the PCT system, an applicant can designate different national or regional offices to serve as ISA and IPEA for their application. Specifically, the USPTO (United States Patent and Trademark Office) serves frequently as an International Searching Authority (ISA), while the EPO often acts in the capacity of an International Preliminary Examining Authority (IPEA). Why other options are incorrect: - **Option A:** While it is possible for the applicant to choose the EPO as ISA, this would not be common practice since the EPO typically serves as IPEA rather than ISA. Additionally, the USPTO can serve as an ISA but is less frequently chosen as an IPEA. - **Option C:** The Austrian Patent Office (APO) does not commonly act in these roles for international patent applications under the PCT system. - **Option D:** Although it might be possible to choose certain regional or national offices for both ISA and IPEA, typically there are specific designations and practical considerations that limit this flexibility. Singapore's Intellectual Property Office is less likely to serve as an IPEA compared to other established entities such as the EPO. The applicant must ensure compliance with PCT rules regarding which offices they designate for these roles and should consider standard practices and availability of services when making their selection.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Article 87(4) and Rule 60(a)(i) of the European Patent Convention (EPC), an applicant has a period of two months from the filing date of the European patent application to correct or add missing priority claims. In this case, EP -II was filed on 3 July 2022, but the correction can be made within two months after the filing of PCT-P (which is 20 June 2023). Therefore, applicant P has until 7 November 2023 to add the missing priority claim from EP -II. Hence, option B is correct.\\n\\n- Option A suggests a deadline of 3 November 2023 which is incorrect because the two-month period starts from 20 June 2023.\\n- Option C states that the time limit expires on 20 October 2023, but this is too early; the correct deadline as per EPC is within two months of filing PCT-P.\\n- Option D suggests that the time period expired already on 3 July 2023, which is incorrect because under Article 87(4), applicant has up to two months from the date of filing the subsequent application (i.e., after filing PCT-P) to correct or add missing priority claims.\\n\\nIn summary, the valid claim for adding a missing priority claim according to EPC rules must be within two months from the filing of the current application, in this case PCT-P. Correcting or adding missing priority should be done before 7 November 2023, making Option B the correct choice.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-III, 6.9, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_9.html\nSource: Guidelines for Examination in the EPO, F-VI, 1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_1_3.html"
                },
                {
                    "Answer": "None of the above",
                    "Justification": "According to the relevant provisions under the European Patent Convention and case law interpretations provided in the legal texts, a third party who is not involved as an appellant or respondent does not have any formal procedural obligations such as requesting an extension period (A), paying a fee for further processing (B), or filing a request for reestablishment of rights with its associated fee (C). There are no provisions in Art. 134 EPC that allow an opponent/respondent to formally extend their response time when they have missed it, fees for further processing are applicable only in specific situations such as filing an appeal after the deadline or dealing with procedural deficiencies, and re-establishment of rights under Art. 136 EPC pertains to situations where a procedural deadline has been missed and there are extraordinary circumstances justifying the restoration of that right. For third-party submissions beyond their initial period, no formal actions such as extension requests, fees for further processing, or reestablishment of rights are required according to Case Law III and Case Law V.\n\nSources:\n\nSource: Case Law III, Q.1.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2_2.html\nSource: Case Law III, Q.3.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_3_2.html\nSource: Case Law III, Q.1.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2.html\nSource: Case Law III, N.2.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_2_3.html\nSource: Case Law V, A.11.3.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_v_a_11_3_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to Rule 142 EPC and the relevant provisions of the Guidelines for Examination in the EPO concerning interruption of proceedings and payment of renewal fees after such an interruption, the correct approach is as follows: The application was filed on 20 March 2020. The third year starts from 21 March 2023 onwards.\\n\\n### Interruption Period:\\nProceedings were interrupted under Rule 142 EPC starting from 10 March 2022 until they resumed on 12 October 2023 (the day the applicant was informed).\\n\\n**Renewal Fee Due Dates:**\\n- **Third year:** The renewal fee for the third year would normally be due by 21 March 2024, but since there is an interruption of proceedings from 10 March 2022 to 12 October 2023, any missed deadlines during this period can still be addressed within a grace period.\\n- **Fourth year:** The renewal fee for the fourth year would normally be due by 21 March 2025 but the same logic applies as with the third year.\\n\\n### Grace Period:\\nAccording to Art. 86(1) in conjunction with Rule 94 and the Guidelines (E-VIII, 2), if a renewal fee is not paid during the interrupted period, it can still be validly paid within six months of the date proceedings are resumed, along with an additional 50% fee.\\n\\n### Correct Answer C:\\nThe applicant has until **31 October 2023** (6 months after 12 April 2023 when proceedings were informed to have resumed) to pay the renewal fees for both the third and fourth years, plus a 50% additional fee if not paid within this period.\\n\\n### Incorrect Options:\\n- **A:** This option is incorrect because, despite no payment of renewal fees, under Rule 142 EPC, there’s still an opportunity to regularize the situation without immediate withdrawal.\\n- **B:** The applicant has six months (not just until resumption) to make up for missed deadlines with a grace period and additional fee, making this option incorrect.\\n- **D:** While it is true that renewal fees can be paid within 6 months of resumption plus an extra fee, the question asks for payment without any additional fee. Thus, this option does not align correctly with the rules allowing a six-month grace period but requiring an additional fee if used.\n\nSources:\n\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-IV, 1.4.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_1_4_3.html"
                }
            ]
        },
        {
            "filename": "2024_EPAC_mcq.json",
            "questions": [
                {
                    "question": "An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.",
                    "options": [
                        "A. Complete and file Form 1200 and pay the filing fee and the search fee",
                        "B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year",
                        "C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative",
                        "D. None of the above statements"
                    ]
                },
                {
                    "question": "A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?",
                    "options": [
                        "A. Six months after the date of mention of the publication of the European search report",
                        "B. Date of mention of the publication of the European search report",
                        "C. The designation fee was validly paid and can no longer be refunded",
                        "D. Date of the start of substantive examination"
                    ]
                },
                {
                    "question": "On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?",
                    "options": [
                        "A. 10 October 2024",
                        "B. 17 October 2024",
                        "C. 18 October 2024",
                        "D. A debit order cannot be revoked in part"
                    ]
                },
                {
                    "question": "The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?",
                    "options": [
                        "A. File a notice of appeal against the decision within four months of notification of the decision",
                        "B. File a request for further processing within two months of notification of the decision",
                        "C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor",
                        "D. A, B and C are correct"
                    ]
                },
                {
                    "question": "Which of the following statements about filing third- party observations is correct?",
                    "options": [
                        "A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations",
                        "B. Third -party observations must be filed in writing and may not be filed anonymously",
                        "C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid",
                        "D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO"
                    ]
                },
                {
                    "question": "You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?",
                    "options": [
                        "A. You must pay two additional search fees by 25 October 2024",
                        "B. You do not need to file a response to the provisional opinion accompanying the partial search results",
                        "C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit",
                        "D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn"
                    ]
                },
                {
                    "question": "An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?",
                    "options": [
                        "A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO",
                        "B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application",
                        "C. File an electronic certified copy of the Luxembourg patent application with the EPO",
                        "D. File a certified copy of the Luxembourg patent application with the International Bureau"
                    ]
                },
                {
                    "question": "Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?",
                    "options": [
                        "A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.",
                        "B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.",
                        "C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.",
                        "D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision."
                    ]
                },
                {
                    "question": "European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?",
                    "options": [
                        "A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X",
                        "B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0",
                        "C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0",
                        "D. No renewal fee has to be paid on 31 October 2024"
                    ]
                },
                {
                    "question": "A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?",
                    "options": [
                        "A. 13 January 2025",
                        "B. 12 January 2025",
                        "C. 22 January 2025",
                        "D. 14 January 2025"
                    ]
                },
                {
                    "question": "Which functionalities or services can be accessed directly from MyEPO Portfolio?",
                    "options": [
                        "A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF",
                        "B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC",
                        "C. Mailbox, patent search via publication server, a shared area with examiners",
                        "D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox"
                    ]
                },
                {
                    "question": "In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?",
                    "options": [
                        "A. When you submit documents after business hours",
                        "B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end",
                        "C. When there is a system outage at the EPO that prevents document submission via the standard filing systems",
                        "D. When the EPO is closed due to an official holiday"
                    ]
                },
                {
                    "question": "Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?",
                    "options": [
                        "A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time",
                        "B. Korhonen is allowed to file the amended claims in Finnish if he then provides a",
                        "translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time",
                        "D. Korhonen is not allowed to file the amended claims in Finnish"
                    ]
                },
                {
                    "question": "Applicants may request processing of their international application under PCT Direct by filing a letter (\"PCT Direct letter\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?",
                    "options": [
                        "A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing",
                        "B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0",
                        "C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0",
                        "D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document"
                    ]
                },
                {
                    "question": "Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?",
                    "options": [
                        "A. Mr Linguist must provide a translation of the specification into Dutch",
                        "B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends",
                        "C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA",
                        "D. Mr Linguist may provide a translation of the specification into Spanish"
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "D",
                    "Justification": "Legal basis Rule 159(1) EPC The examination fee and designation fee must also be paid ( six months  after publication of search report ; payment cannot be postponed to 31 m onths  if there is a wish to enter into the European phase at 25 months )."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, A-X, 5.2.2 “The designation fee falls due upon publication of the mention of the European search report. It may be paid within six months of the mentioned date of publication (Rules 39(1) , 17(3)  and 36(4) ). Where paid before the due date, e.g. upon filing of the application, the designation fee will however be retained by the EPO. These payments will only be considered valid as from the due date, provided that the amount paid corresponds to the amount payable on the due date (…)”"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis OJ EPO  2024, Supplementary Publication 2,  Arrangements for deposit accounts (ADA), 13.2 “13.2: A debit order with a deferred payment date (…) may be revoked in whole or in part in Central Fee Payment until one day before the date specified as the execution date at the latest. ”"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Articles 106 and 108 EPC ; Article 121(1) EPC ; Guidelines for Examination in the EPO, E-VIII, 2 A notice of appeal could also be filed within two months of  notification of the decision; re-establishment of rights is excluded because further processing is available."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Article 115 EPC, R ule 114 EPC ; Guidelines for E xamination in the EPO,  E-VI.3 2 A. Incorrect: a third party filing observations concerning the patentability of an application or patent is not a party to the proceedings; the  applicant may respond to third- party observations but is not obliged to do so B. Incorrect: third- party observations may be filed anonymously C. Incorrect: there is no official fee when filing third- party observations D. Correct"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 40 PCT A. Incorrect: may be paid but not must be paid B. Correct C. Incorrect: only one protest fee is due (Rule 40.2(e) PCT) D. Incorrect: if the applicant does not pay any additional search fees, the information appearing in the invitation to pay additional fees will be considered to be  the result of the international search and will be included as such in the international search report"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis PCT Applicant's Guide 5.070. ; Guidelines for Examination in the EPO  A-III, 6.7; PCT Applicant's Guide LU-Luxembourg A. Only available if the priority application and the PCT application are filed with the same p atent office B. Incorrect: the LPTO does not use the DAS  access code C. Incorrect: the LPTO does not issue electronic priority document s D. Correct"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Article 107 EPC A. Incorrect: B is not adversely a ffected B. Correct: both parties A and B are adversely affected C. Incorrect: third  parties are no t parties to  the proc eedings D. Incorrect:  withdrew its opposition; no longer a party to the proceedings"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis 3 Guidelines for Examination in the EPO, A- X, 5.2.4 The renewal fee that would have been due on 31 October had to be paid for the decision to grant to be issued (this is one of the warnings in the communication under Rule 71(3)  EPC)."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Rule 126(2) EPC The document was delivered to the addressee nine days after the date it bears, so the period expires later by the number of days by which the seven days were exceeded, i.e. 12 January 2025 + two  days. E vidence of late receipt needs to be filed with the response."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis https://www.epo.org/en/applying/myepo- services/interact A. Incorrect : it is neither  possible  to access the European Patent Register n or to file using  the EPO's legacy O nline Filing software (eOLF)  via MyEPO Portfolio B. Correct C. Incorrect : it is not possible to access  the European P ublication Server via MyEPO Portfolio D. Incorrect : it is neither  possible to access the European P ublication Server nor to file using the EPO's Online Filing 2.0  via MyEPO Portfolio"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis OJ EPO 2023, A50 , point  20; Contingency Upload Service | epo.org"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, A-VII, 3.2; Rule 3(2) EPC Since the response with the amendments has to be filed within  a time limit, the Finnish applicant is entitled to file the amended claims  in Finnish. A translation of a document filed in an admissible non- EPO language into an official language of the EPO must be filed within a non- extendable period of one month (Rule  6(2) EPC). This means that a translation of the amended claims must be filed in the language of proceedings , English  in this case  (Rule 3(2) EPC ). 4"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis PCT-EPO  Guidelines , B-IV, 1.2 . Comment s are required but not amendments."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Article 6(1) Regulation (EU) No 1260/2012; R ule 6(2)(d) UPR; Unitary Patent Guide, para. 65 The translation may be in any of the 24 official languages of the EU, except English, irrespective of the language in which the application was filed or the geographical extent of the unitary effect."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "A",
                    "Justification": "According to Article 23(2) PCT and Rule 44bis.2 PCT as provided in the Guidelines for Examination in the EPO (E-IX, 2.8), an applicant can request early processing of their international application with the EPO before expiry of the period under Art. 22 PCT. If a request for early processing is made and the International Bureau has not yet transmitted necessary documents to the EPO, this will expedite the procedure. Since in this scenario, the CNIPA search report was already issued within 18 months + 1 day after filing, an express request by the applicant can be made to initiate early examination at the EPO. The correct actions for entry into the EP phase as stated in Option A are: - Completing and filing Form 1200: This is necessary for entering the European regional phase. - Paying the filing fee and search fee: These fees need to be paid when entering the European phase, regardless of whether early processing has been requested. The other options do not correctly reflect all required actions: Option B includes paying a renewal fee for the third year. However, according to the provided information and the legal context, no such fee is necessary at this stage of entry into the EP phase unless specifically required by national law (which in this case isn't indicated). Option C incorrectly adds appointing a representative as a requirement for early processing under Art. 23 PCT/Rule 44bis.2 PCT; while appointing a European patent attorney is beneficial, it is not a prerequisite for filing an entry request and paying the necessary fees. Therefore, Option D ('None of the above statements') is incorrect since Option A correctly captures all the steps required according to the provided context.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-II, 6.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_4.html\nSource: Guidelines for Examination in the EPO, A-II, 5.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_5_4.html\nSource: Guidelines for Examination in the EPO, C-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_3.html\nSource: Guidelines for Examination in the EPO, C-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vi_3.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_8.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Rule 71(2) of the EPC, an application may be withdrawn at any time before it is granted. The applicant can obtain a refund of fees, including the designation fee, if the application is withdrawn before grant and after paying these fees. An application shall not be deemed to have been withdrawn under paragraph (2) unless notice in writing of withdrawal has been received by the European Patent Office at a time when the application remains pending. If an applicant withdraws an application before grant and after paying any fees due, these fees will be refunded. The date of notification of such decision is determined as indicated in E-II, 2 (which implies that it is not the internal postal service handover date but rather the actual date on which the communication is sent). Therefore, based on Rule 71(2), Rule 71(3) and E-II, 2, the correct answer is B.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-X, 10.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_10_2_5.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to the Guidelines for Examination in the EPO under A-X, 6.2.1, if a fee paid by bank transfer enters the EPO's bank account after the period in which it should have been made, the payer must provide evidence that they fulfilled one of two conditions within the relevant time frame: either (i) payment of the fee was effected through a banking establishment or (ii) an order was duly given to a banking establishment to transfer the amount of the payment. Given this context, if the applicant realizes by 10 October 2024 that the renewal fee should not have been included in the debit order, they need to ensure that the bank does not execute the order to debit and transfer this specific fee.\\nThe Guidelines imply that if an applicant wants to avoid a fee being charged improperly due to a mistake in their instruction, they must act before the bank executes the transaction. This means the latest point to revoke or modify the order would be right before it is executed by the bank on 18 October 2024.\\nWhy other options are incorrect:\\n- **Option A (10 October 2024):** While this date might seem correct at first glance, the applicant still needs time to formally communicate with their banking institution and ensure that they can prevent the execution of an improper debit order on 18 October 2024.\\n- **Option C (18 October 2024):** On this date, the transaction will have been executed. Once it has entered into the EPO's bank account, any further rectifications would be too late as per the guidelines mentioned in A-X, 6.2.5, which discuss refunds and evidence of timely payment.\\n- **Option D (A debit order cannot be revoked in part):** This is incorrect because under certain circumstances, the applicant can indeed revoke or modify a debit order before its execution according to common banking practices and procedures outlined for fee payments to the EPO.\\nTherefore, by 17 October 2024, the applicant has ample time to communicate with their bank to ensure that only appropriate fees are debited on 18 October 2024.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 4.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_4_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_1_1.html\nSource: Guidelines for Examination in the EPO, C-V, 4.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_4_2.html\nSource: Guidelines for Examination in the EPO, C-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_3.html\nSource: Guidelines for Examination in the EPO, A-X, 6.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_6_2_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "According to the Guidelines for Examination in the EPO and Article 122 EPC, an applicant who fails to comply with a procedural time limit may request re-establishment of rights if they can show that non-compliance was not attributable to any fault on their part and they file such a request within two months from when they became aware or should have been aware of the lapse. In this scenario, since the Receiving Section issued a decision refusing the application after missing the time limit for filing the designation of inventor (Rule 60 EPC), the applicant can file a request for re-establishment of rights under Article 122 and Rule 136 in order to restore their right to proceed with the patent application. This must be done within two months from when they became aware or should have been aware of the lapse.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, E-VIII, 3.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_3_1_1.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: Guidelines for Examination in the EPO, E-X, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_x_1_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "The statement that 'Third-party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO' is correct according to the provided legal text. After the publication of a European patent application under Art. 93, third-party observations can indeed be submitted by any person, but these observations need to comply with specific requirements such as being filed in writing in one of the three languages (English, French, or German) officially recognized at the EPO.\\n\\nWhy other options are incorrect:\\n- Option A: 'The person that filed third-party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third-party observations' is incorrect. According to the guidelines, the person filing such observations may not become a party to the proceedings, and there's no obligation for the applicant to formally respond to all submitted third-party observations.\\n- Option B: 'Third-party observations must be filed in writing and may not be filed anonymously' is partially correct but incomplete because it omits mentioning that third-party observations can indeed be filed anonymously. Observations do need to be submitted in writing, but anonymity is allowed under the rules provided by the EPO (see OJ EPO 2017, A86).\\n- Option C: 'Third-party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid' is incorrect because while third-party observations must include a statement of the grounds upon which they are based, there's no requirement for an additional fee to be paid according to the mentioned guidelines.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_vi_2.html\nSource: Guidelines for Examination in the EPO, C-I, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_i_2.html\nSource: Guidelines for Examination in the EPO, D-IV, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_iv_3.html\nSource: Guidelines for Examination in the EPO, E-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_vi_3.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to Rule 17(1)(b) of the PCT, if a communication is issued by the ISA identifying multiple inventions and inviting the payment of additional search fees, failure to pay these fees within the time limit specified in Article 16(3) will result in the international application being deemed withdrawn. The given problem involves a communication from the EPO as an International Searching Authority (ISA), stating that there is a requirement for unity of invention with respect to three inventions and inviting payment of two additional search fees by 25 October 2024. If this deadline is missed, the international patent application will be deemed withdrawn according to Rule 17(1)(b). In conclusion, the correct answer is D since not paying the additional search fees by 25 October 2024 will result in the application being deemed withdrawn.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, B-XI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_xi_2.html\nSource: Guidelines for Examination in the EPO, B-II, 4.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_ii_4_5.html\nSource: Guidelines for Examination in the EPO, B-VII, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_vii_1_2.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html"
                },
                {
                    "Answer": "B",
                    "Justification": "According to Rule 20(1) of the Patent Cooperation Treaty (PCT), a certified copy of an earlier application must be furnished when it is required in order to claim the priority of that earlier application. The PCT实施细则进一步规定，申请人可以通过数字访问服务（DAS）代码授权国际局获取所需的优先权文件。在本案例中，根据PCT细则，正确的做法是提交一个有效的DAS码给国际局，让其能够获得所需优先权文件的认证副本。\\n\\n**Why the other options are incorrect:**\\n- **Option A:** Requesting the Luxembourg Intellectual Property Office to prepare and send a certified copy directly to the EPO is not explicitly provided for under PCT rules. While it may be possible, this approach does not comply with the preferred method outlined in the实施细则.\\n\\n- **Option C:** Filing an electronic certified copy of the Luxembourg patent application with the EPO would not align with the PCT requirement that the certified copy must be obtained through the DAS service by the International Bureau.\\n\\n- **Option D:** Submitting a certified copy to the International Bureau is not consistent with the procedures outlined in the PCT实施细则. According to Rule 20, it is the International Bureau's responsibility to obtain the certified copies via DAS when provided with the valid code.\\n\\nTherefore, according to the legal context and rules of the PCT, option B correctly identifies the proper course of action for providing a certified copy through digital means as specified by the PCT.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-IV, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_6.html\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, C-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "This statement is correct because according to Article 107(2) EPC, a party who has submitted evidence or made observations in support of an opponent can appeal if the opposition division decides to maintain the European patent unamended. In this case, Firm C filed observations under Article 115 EPC and argued against the novelty of the granted claims based on document D2. If the opposition division decided to maintain the patent as granted despite these arguments, Firm C would be entitled to appeal.\n\nSources:\n\nSource: Case Law III, N.2.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_2_3.html\nSource: Case Law III, Q.1.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2_2.html\nSource: Guidelines for Examination in the EPO, D-I, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_i_6.html\nSource: Case Law III, Q.3.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_3_2.html\nSource: Case Law III, Q.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to Article 86(1) and Rule 50 EPC, renewal fees for a granted European patent become due at the end of each year from the date of grant publication (Art. 82(1)). In this case, EP -X was published as granted on October 2, 2024, so the first renewal fee would be due on October 2, 2025, which is for the period ending October 2, 2026 (the start of year 2 post-grant). The request for unitary effect was registered on October 10, 2024. However, this does not affect the renewal fee schedule since it only pertains to the territorial extent and not the timing of renewal fees. Thus, no renewal fee has to be paid by October 31, 2024 based on the timeline provided and legal obligations outlined in the EPC.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, E-VIII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_2.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, A-IV, 1.4.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_1_4_3.html"
                },
                {
                    "Answer": "A",
                    "Justification": "The rules under Rule 127(2) of the EPC Guidelines state that if there is evidence indicating receipt later than the document's dated day, this actual receipt date can be considered instead of the original delivery date. In this case, since the applicant received the communication on 21 September 2024 (as evidenced by a signed postal receipt), the four-month time limit starts from 21 September 2024. Therefore, the last day for replying to the communication is 13 January 2025.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 1.7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_7.html\nSource: Guidelines for Examination in the EPO, C-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_3.html\nSource: Guidelines for Examination in the EPO, E-VIII, 1.6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_6_1.html\nSource: Guidelines for Examination in the EPO, C-VI, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vi_1_1.html\nSource: Guidelines for Examination in the EPO, E-II, 2.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ii_2_3.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to the Guidelines for Examination in the EPO and related documentation:\\n\\n1. **MyEPO Portfolio:** This service provides comprehensive functionalities for managing European patent applications, including filing via Online Filing 2.0 (part of eOLF - EPO Online Filing), access to the publication server for patent searches, and a Mailbox for receiving communications from the EPO under Article 94(3).\\n\\n2. **Option D:** This option correctly identifies three key functionalities or services that can be accessed directly through MyEPO Portfolio: \\n   - **Filing via the EPO's Online Filing 2.0**: Applicants must use the prescribed request for grant form (EPO Form 1001) available on the EPO website.\\n   - **Patent search via publication server**: The Publication Server is indeed part of the services that can be accessed through MyEPO Portfolio or other EPO online tools.\\n   - **Mailbox**: Mailbox allows users to receive communications from examiners and respond accordingly.\\n\\n**Why Other Options Are Incorrect:**\\n- **Option A:** While a shared area with examiners, European Patent Register, and filing via eOLF are useful features, the European Patent Register is not typically accessed directly through MyEPO Portfolio in this manner.\\n- **Option B:** This option includes \\\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, A-II, 4.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_4_1_1.html\nSource: Guidelines for Examination in the EPO, GeneralPart, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/foreword_4.html\nSource: Guidelines for Examination in the EPO, A-II, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_1.html"
                },
                {
                    "Answer": "When there is a system outage at the EPO that prevents document submission via the standard filing systems.",
                    "Justification": "The EPO Contingency Upload Service is designed specifically for situations where the main patent application and response submission systems are not accessible due to planned outages or unexpected technical issues on the EPO's end. This service does not cover submitting documents after business hours, personal technical setup issues, or during official holidays.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_7.html\nSource: Guidelines for Examination in the EPO, F-III, 10, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_iii_10.html\nSource: Guidelines for Examination in the EPO, A-III, 3.2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_3_2_2.html\nSource: Guidelines for Examination in the EPO, A-II, 6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_1.html\nSource: Guidelines for Examination in the EPO, A-II, 6.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to the Guidelines for Examination in the EPO, A-VII, 2, once an application is translated into one of the official languages of the EPO (English, French or German), that language becomes the 'language of the proceedings.' Since Korhonen provided an English translation of his Finnish application within the required time frame, English is now the language of the proceedings. Therefore, Korhonen cannot file amended claims in Finnish because according to Article 14(3) as detailed in A-VII, 2 of the Guidelines for Examination in the EPO, any amendments must be made in the language of proceedings (English).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, E-V, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_v_1.html\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_7.html"
                },
                {
                    "Answer": "D",
                    "Justification": "According to Rule 56(3) of the PCT and related EPO Guidelines, there is no requirement that amended claims must be included in a single PDF document when filing under PCT Direct. The core of PCT Direct is to request early examination by providing informal comments addressing objections raised in the search report for the priority application.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, G-IV, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iv_5_2.html\nSource: Guidelines for Examination in the EPO, A-II, 6.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_4.html\nSource: Guidelines for Examination in the EPO, B-III, 3.3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_iii_3_3_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_3.html"
                },
                {
                    "Answer": "None of the given options are entirely correct as stated in the Guidelines for Examination at the EPO.",
                    "Justification": "According to Article 76(2) EPC and Rule 93(1) EPC, when requesting unitary effect, a translation of the application documents into one of the official languages of the European Patent Office (EPO) must be provided. The official languages are English, French, or German. Mr Linguist filed his patent application in Dutch but used English as the language for proceedings. Therefore, he would already have to ensure that any necessary documentation meets EPO standards with one of its official languages. Option A is incorrect because Dutch is not an EPO official language for unitary effect requests. Option B and C are incorrect because they specify state-level rather than EPO-official language requirements. Option D is incorrect because Spanish is not an official language of the European Patent Office.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-V, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_v_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, E-V, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_v_6.html\nSource: Guidelines for Examination in the EPO, E-XIII, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_xiii_4.html"
                }
            ]
        }
    ]
}